Magenta therapeutics inc.

Major-Pharmaceuticals

MGTA


100 Technology Square
Cambridge , MA 02139

Executive/
Director

Price

  • Last Close
  • $ 0.7
    $ -0.06 -7.65 %
    Sep 11, 2023
  • 52-Week High/Low
  • $0.78 - $0.7
  • YTD
  • 0%

  • Trading Volume
  • 376,060
  • Market Cap Full
  • $ 10.4M
  • Shares Outstanding
  • 14.8M
    Nov 9, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - 189% -5% 51% -34.5% 101.3% -
Q2 - - - -7% -8.9% 4% -17.4% -58.6% -4.7% -
Q3 - - - -11.6% -30.4% 8% -25.6% 17.5% -7.7% -
Q4 - - - -51.1% 51.2% 15.3% -39.2% -72% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 38.5% 47.5% -1.5% -1.4% -17.5% 17.2% 5.8% -6.5% -6.7% - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%165%-48%-43%-91%77%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022
Q1 - - - -4.53 -0.44 -0.51 -0.36 -0.39
Q2 - - - -3.13 -0.48 -0.48 -0.32 -0.29
Q3 - - - -0.49 -0.54 -0.37 -0.3 -0.27
Q4 - - - - -0.61 -0.35 -0.31 -0.34
A 0 0 0 -8.2 -2.1 -1.7 -1.3 -1.3

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 33.5 39.3 48.6 58.8 60.6
Jun - 33.7 39.5 48.6 58.8 60.6
Sep 32.9 38.8 48.3 58.6 58.9 60.7
Dec 33.2 39 48.3 58.8 60.6 14.8

Financial Ratios

20202019201820172016
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 20.9 13.4 25.4 162.4 -19.9
Equity multiplier 0.1 0.1 0.1 -0.1 -0.1